Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • CRI’s 7th Annual Patient Immunotherapy Summit – December 2023 Full Cut 

    The Cancer Research Institute’s 7th Annual Patient Immunotherapy Summit hosts a plethora of impactful information that cancer…
    January 8, 2024| Max Mallet
  • Follow Along as Philanthropist Lance Kawaguchi Treks to the South Pole for Cancer Research 

    There are a variety of ways to raise money for Cancer Research Institute (CRI) to support cancer…
    December 22, 2023| Max Mallet
  • 5 Reasons to Give to CRI Before Year’s End 

    It is a busy time of year dotted with holidays as 2023 comes to a close. At…
    December 14, 2023| Max Mallet
  • Give the Gift of Cancer Immunotherapy Research 

    It is the thick of the holiday season, and you might be thinking of giving generously to…
    December 12, 2023| Max Mallet
  • CRI Immunologists Are Armed Against Lung Cancer, the Most Common Cancer Worldwide 

    A Large Cancer Presence on a Global Scale  The Cancer Research Institute (CRI) has a singular focus:…
    November 17, 2023| Max Mallet
  • How CRI is Taking on Pancreatic Cancer, “The Silent Killer” 

    Immunotherapy holds the greatest promise for optimizing outcomes for cancer patients, and eventually finding a cure for…
    November 9, 2023| Max Mallet
  • 6 CRI-Affiliated Scientists Elected to the National Academy of Medicine 

    The National Academy of Medicine (NAM), an organization that has worked on critical issues at the intersection…
    November 2, 2023| Max Mallet
  • Honoring Hispanic Immunologists During National Hispanic Heritage Month

    Immunotherapy is the most forward-thinking and promising treatment for many types of cancers. Outcomes for childhood cancers,…
    October 12, 2023| Max Mallet
  • Prostate Cancer: A Unique and Common Cancer Affecting Men 

    Most cancers affect everyone, regardless of sex, race, age, and other factors. Prostate cancer, however, only affects…
    October 2, 2023| Max Mallet

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute